Page last updated: 2024-10-24

chlorambucil and Hepatitis C

chlorambucil has been researched along with Hepatitis C in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rollino, C1
Roccatello, D1
Giachino, O1
Basolo, B1
Piccoli, G1

Other Studies

1 other study available for chlorambucil and Hepatitis C

ArticleYear
Hepatitis C virus infection and membranous glomerulonephritis.
    Nephron, 1991, Volume: 59, Issue:2

    Topics: Chlorambucil; Female; Glomerulonephritis, Membranous; Hepatitis Antibodies; Hepatitis C; Humans; Mal

1991